2 Top Stocks to Buy in August and Hold Forever
Technological progress sometimes renders products or entire industries completely obsolete. That's true even within the healthcare sector, which as a whole is unlikely to fall out of style anytime soon. Even so, individual healthcare companies must constantly innovate to stay relevant and deliver consistent performances over the long run.
With that said, let's look at two healthcare stocks with solid track records of innovation and are worth buying and holding onto for good: Regeneron (NASDAQ: REGN) and Abbott Laboratories (NYSE: ABT).
Source Fool.com
Regeneron Pharmaceuticals Inc. Stock
€1,036.5
0.780%
The stock is one of the favorites of our community with 48 Buy predictions and 1 Sell predictions.
With a target price of 1072 € there is a slightly positive potential of 3.42% for Regeneron Pharmaceuticals Inc. compared to the current price of 1036.5 €.
